# FIDUS INVESTMENT Corp: financial statements, quarterly

FDUS · Nasdaq · CIK 1513363 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fdus.md) · [Financials](/companies/fdus/financials.md) · [Filings](/companies/fdus/filings.md) · [Insiders](/companies/fdus/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fdus/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [5.4](/filings/0000950170-24-119521.md) | [5.4 d](/filings/0001193125-26-076572.md) | [5.5](/filings/0000950170-25-066925.md) | [5.6](/filings/0000950170-25-105009.md) | [5.5](/filings/0001193125-25-269489.md) | [5.7 d](/filings/0001193125-26-076572.md) | [6.2](/filings/0001193125-26-211915.md) | [7.0](/filings/0001193125-26-337982.md) | [6.9](/filings/0001193125-25-269489.md) | [8.7 d](/filings/0001193125-26-076572.md) | [9.0](/filings/0001193125-26-211915.md) | [10.1](/filings/0001193125-26-337982.md) |
| Income tax | $m | [0.0](/filings/0000950170-24-119521.md) | [1.0 d](/filings/0000950170-25-034612.md) | [(0.0)](/filings/0000950170-25-066925.md) | [0.1](/filings/0000950170-24-089256.md) | [0.6](/filings/0000950170-24-119521.md) | [1.8 d](/filings/0000950170-25-034612.md) | [0.0](/filings/0000950170-25-066925.md) | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [7.7](/filings/0000950170-23-058180.md) | [9.5 d](/filings/0000950170-24-023065.md) | [20.1](/filings/0000950170-25-066925.md) | [24.1](/filings/0000950170-25-105009.md) | [16.5](/filings/0001193125-25-269489.md) | [17.6 d](/filings/0001193125-26-076572.md) | [19.7](/filings/0001193125-26-211915.md) | [25.3](/filings/0001193125-26-337982.md) | [19.1](/filings/0001193125-25-269489.md) | [18.3 d](/filings/0001193125-26-076572.md) | [19.9](/filings/0001193125-26-211915.md) | [20.0](/filings/0001193125-26-337982.md) |
| Diluted EPS | $ per share | [0.63](/filings/0001193125-26-076572.md) | [0.58](/filings/0001193125-26-076572.md) | [0.57](/filings/0001193125-26-076572.md) | [0.53](/filings/0001193125-26-076572.md) | [0.64](/filings/0001193125-26-076572.md) | [0.55](/filings/0001193125-26-076572.md) | [0.53](/filings/0001193125-26-211915.md) | [0.53](/filings/0001193125-26-337982.md) | [0.49](/filings/0001193125-26-076572.md) | [0.53](/filings/0001193125-26-076572.md) | [0.65](/filings/0001193125-26-211915.md) | [0.49](/filings/0001193125-26-337982.md) |
| Basic EPS | $ per share | [0.63](/filings/0001193125-26-076572.md) | [0.58](/filings/0001193125-26-076572.md) | [0.57](/filings/0001193125-26-076572.md) | [0.53](/filings/0001193125-26-076572.md) | [0.64](/filings/0001193125-26-076572.md) | [0.55](/filings/0001193125-26-076572.md) | [0.53](/filings/0001193125-26-211915.md) | [0.53](/filings/0001193125-26-337982.md) | [0.49](/filings/0001193125-26-076572.md) | [0.53](/filings/0001193125-26-076572.md) | [0.65](/filings/0001193125-26-211915.md) | [0.49](/filings/0001193125-26-337982.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [80.3](/filings/0000950170-23-058180.md) | [119](/filings/0001193125-26-076572.md) | [27.1](/filings/0000950170-24-052089.md) | [48.3](/filings/0000950170-24-089256.md) | [54.4](/filings/0000950170-24-119521.md) | [57.2](/filings/0001193125-26-076572.md) | [67.5](/filings/0000950170-25-066925.md) | [91.2](/filings/0000950170-25-105009.md) | [62.3](/filings/0001193125-25-269489.md) | [70.0](/filings/0001193125-26-337982.md) | [49.7](/filings/0001193125-26-211915.md) | [37.6](/filings/0001193125-26-337982.md) |
| Total assets | $m | [1,023](/filings/0000950170-23-058180.md) | [1,091](/filings/0000950170-25-034612.md) | [1,093](/filings/0000950170-24-052089.md) | [1,146](/filings/0000950170-24-089256.md) | [1,161](/filings/0000950170-24-119521.md) | [1,164](/filings/0001193125-26-076572.md) | [1,242](/filings/0000950170-25-066925.md) | [1,257](/filings/0000950170-25-105009.md) | [1,278](/filings/0001193125-25-269489.md) | [1,427](/filings/0001193125-26-337982.md) | [1,444](/filings/0001193125-26-211915.md) | [1,501](/filings/0001193125-26-337982.md) |
| Total liabilities | $m | [474](/filings/0000950170-23-058180.md) | [501](/filings/0000950170-25-034612.md) | [484](/filings/0000950170-24-052089.md) | [499](/filings/0000950170-24-089256.md) | [502](/filings/0000950170-24-119521.md) | [508](/filings/0001193125-26-076572.md) | [564](/filings/0000950170-25-066925.md) | [565](/filings/0000950170-25-105009.md) | [567](/filings/0001193125-25-269489.md) | [685](/filings/0001193125-26-337982.md) | [702](/filings/0001193125-26-211915.md) | [763](/filings/0001193125-26-337982.md) |
| Long-term debt | $m | [454](/filings/0000950170-23-058180.md) | [476](/filings/0000950170-24-023065.md) | [463](/filings/0000950170-24-052089.md) | [473](/filings/0000950170-24-089256.md) | [479](/filings/0000950170-24-119521.md) | [484](/filings/0000950170-25-034612.md) | [546](/filings/0000950170-25-066925.md) | [540](/filings/0000950170-25-105009.md) | [544](/filings/0001193125-25-269489.md) | [658](/filings/0001193125-26-076572.md) | [682](/filings/0001193125-26-211915.md) | [740](/filings/0001193125-26-337982.md) |
| Shareholders' equity | $m | [549](/filings/0000950170-24-119521.md) | [589](/filings/0001193125-26-076572.md) | [608](/filings/0001193125-25-269489.md) | [647](/filings/0001193125-25-269489.md) | [659](/filings/0001193125-25-269489.md) | [656](/filings/0001193125-26-337982.md) | [678](/filings/0001193125-26-337982.md) | [692](/filings/0001193125-26-337982.md) | [711](/filings/0001193125-25-269489.md) | [742](/filings/0001193125-26-337982.md) | [742](/filings/0001193125-26-337982.md) | [738](/filings/0001193125-26-337982.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.2 d](/filings/0000950170-24-119521.md) | [3.4 d](/filings/0001193125-26-076572.md) | [(77.8)](/filings/0000950170-25-066925.md) | [(2.7) d](/filings/0000950170-25-105009.md) | [4.7 d](/filings/0001193125-25-269489.md) | [20.5 d](/filings/0001193125-26-076572.md) | [(50.2)](/filings/0001193125-26-211915.md) | [39.9 d](/filings/0001193125-26-337982.md) | [(31.9) d](/filings/0001193125-25-269489.md) | [(105) d](/filings/0001193125-26-076572.md) | [(32.6)](/filings/0001193125-26-211915.md) | [(41.9) d](/filings/0001193125-26-337982.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.4](/filings/0000950170-23-058180.md) | [24.8](/filings/0000950170-24-052089.md) | [25.0](/filings/0000950170-24-089256.md) | [26.6](/filings/0000950170-24-119521.md) | [30.8](/filings/0000950170-25-066925.md) | [32.2](/filings/0000950170-25-105009.md) | [33.4](/filings/0001193125-25-269489.md) | [34.1](/filings/0001193125-26-211915.md) | [35.2](/filings/0001193125-26-337982.md) | [35.7](/filings/0001193125-25-269489.md) | [38.0](/filings/0001193125-26-211915.md) | [38.0](/filings/0001193125-26-337982.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 37,954,364 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337982.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.